Herbs (Global Traditional) · Amazonian
Açai (Euterpe oleracea) (Euterpe oleracea)
Moderate Evidencebotanical3 PubMed Studies
Hermetica Superfood Encyclopedia
Açai (Euterpe oleracea) is an Amazonian superfruit containing high concentrations of anthocyanins, particularly cyanidin-3-glucoside, which provides potent antioxidant activity. These bioactive compounds work by scavenging free radicals and modulating inflammatory pathways to support cardiovascular health and cellular protection.
Açai derives from the purple-black drupe fruit of Euterpe oleracea Mart., a palm tree native to Amazon rainforest floodplains, primarily in Brazil. The fruit is harvested from wild or cultivated trees and processed through hydroalcoholic or aqueous extraction methods from pulp, seeds, or whole fruit to yield polyphenol-rich extracts containing anthocyanins, flavonoids, and phenolic acids.
Human clinical evidence is limited to small-scale trials showing modest metabolic benefits, with a systematic review (PMID: 22607647) grading available data as low evidence overall. A pilot RCT (n=12, PMID: 31307842) found açai beverages reduced oxidative stress in dyslipidemic adults, while an integrative review of trials (total n~200-300) showed improvements in antioxidant defense and HDL-cholesterol.
Clinically studied doses include açai pulp/juice beverages at 200-400 mL/day (containing 50-200 mg polyphenol equivalents) for 4-12 weeks. Powder or standardized extract forms lack detailed human dosing data. Consult a healthcare provider before starting any new supplement.
Açaí pulp (100g freeze-dried powder basis unless noted) is nutrient-dense with a distinctive macronutrient profile: Fat 32–52g (predominantly oleic acid 56%, palmitic acid 24%, linoleic acid 13% of total fatty acids), Carbohydrates 44–52g (with low digestible sugars; high insoluble fiber ~44g/100g dry weight), Protein 8–9g containing all essential amino acids. Micronutrients per 100g fresh pulp: Calcium 260mg, Potassium 896mg, Magnesium 105mg, Manganese 3.4mg (170% DV), Iron 4.4mg, Copper 1.2mg, Zinc 0.9mg, Phosphorus 89mg. Vitamins: Vitamin E (alpha-tocopherol) 15–45mg/100g dry weight (notably high), Vitamin C relatively low at 9–11mg/100g fresh pulp (degrades rapidly post-harvest). Bioactive compounds: Total anthocyanins 1,000–3,300mg/100g dry weight (cyanidin-3-glucoside and cyanidin-3-rutinoside as primary forms, comprising ~64% of polyphenols); Total polyphenols 4,500–12,000mg GAE/100g dry weight; Proanthocyanidins (B1, B2 dimers) ~1,200mg/100g dry weight; Hydroxycinnamic acids including ferulic, p-coumaric, and caffeic acid derivatives ~200–400mg/100g; Sterols: beta-sitosterol ~78mg/100g dry weight. Bioavailability notes: Anthocyanin bioavailability from açaí is estimated at 1.9–11% (urine recovery studies); co-consumption with fat significantly enhances polyphenol absorption given the high lipid matrix; cyanidin metabolites (protocatechuic acid, vanillic acid) detected in plasma within 2h post-consumption; fiber fraction may limit absorption of some micronutrients; freeze-drying preserves >85% of polyphenol content versus fresh pulp, while pasteurization reduces anthocyanins by ~15–20%.
Açai's anthocyanins, particularly cyanidin-3-glucoside and cyanidin-3-rutinoside, activate Nrf2 antioxidant response pathways and inhibit NF-κB inflammatory signaling. These compounds reduce prostaglandin E2 (PGE2) and nitric oxide (NO) production while enhancing endogenous antioxidant enzyme activity. The polyphenols also modulate lipid metabolism by improving reverse cholesterol transport and HDL functionality.
A pilot randomized controlled trial (n=12) demonstrated significant improvements in antioxidant defense markers and reduced oxidative stress following açai supplementation. Integrative reviews of clinical trials involving 200-300 total participants showed enhanced HDL-cholesterol levels and improved lipid profiles. Small human studies and preclinical research confirm reductions in inflammation markers including PGE2 and NO. However, most human studies are limited by small sample sizes and short duration, requiring larger long-term trials for definitive therapeutic claims.
Açai is generally well-tolerated with minimal reported adverse effects in clinical studies. Potential allergic reactions may occur in individuals sensitive to palm family plants or other berries. Due to limited safety data, pregnant and breastfeeding women should avoid açai supplements beyond normal dietary intake. Açai may theoretically interact with anticoagulant medications due to its polyphenol content, though no specific drug interactions have been documented in clinical literature.
